Themis Medicare Ltd Split

228.04
(3.80%)
Jul 23, 2024|03:32:37 PM

Themis Medicare CORPORATE ACTIONS

24/07/2023calendar-icon
23/07/2024calendar-icon
PurposeAnnouncement DateSplit DateRecord DateFace Value (before split)Face Value (after split)
Split13 May 202310 Oct 202310 Oct 2023101
The Board considered the proposal for sub-division of 1 equity share of the Company having facé value of Rs.10/- each into 10 ({Ten) equity shares having face value of Rs.1/- each, subject to regulatory/statutory approvals as may be required and the approval of the shareholders of the Company. 7. The Board considered the proposal for sub-division of 1 equity share of the Company having face value of Rs.10/- each into 10 (Ten) equity shares having face value of Rs.1/- each, subject to regulatory/statutory approvals as may be required and the approval of the shareholders of the Company. Further, the Board recommended consequential amendments in the Capital Clause of the Memorandum of Association of the Company and Articles of Association of the Company, subject to approval of the Shareholders of the Company. The record date for the sub-division of equity shares shall be decided by the Board and will be intimated to the exchanges. The detailed disclosure as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations. 2015 read with SEBI Circular No. CIR/CFD/CMD/ 4/2015 dated September 9, 2015 is enclosed herewith as Annexure ll. Please find our intimation under Regulation 42 of the SEBI (LODR) Regulations, 2015 (As Per BSE Announcement Dated on 20/09/2023) Trading Members of the Exchange are hereby informed that THEMIS MEDICARE LTD., has fixed Record Date for the purpose of Sub-Division of the Equity Shares of the Company :- DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE THEMIS MEDICARE LTD. (530199) RECORD DATE 10.10.2023 PURPOSE Subdivision of existing Equity Shares from One Equity Share of Rs.10/- each into Ten Equity Shares of Re. 1/- each. SUB-DIVIDED PAID-UP VALUE Re.1/- SUB-DIVIDED PAID-UP VALUE W.E.F. 10/10/2023 DR-630/2023-2024 Note: - i. ISIN No. INE083B01016 of Rs. 10/- paid up will not be valid for transactions done on the Exchange on or after 10/10/2023. ii. The new ISIN Number for Re. 1/- paid up will be informed to the market by a separate notice. (As Per BSE Notice Dated on 26..09.2023) Sub: Change in ISIN - Themis Medicare Limited (THEMISMED) Members of the Exchange are hereby informed that the ISIN Code for the equity shares of the following company shall be changed w.e.f. October 10, 2023. Symbol THEMISMED Company Name Themis Medicare Limited New ISIN INE083B01024 Remarks Sub-Division from Rs. 10/- to Re. 1/- The new ISIN shall be effective for all trades done on and from the Ex-date date i.e., October 10, 2023. For and on behalf of National Stock Exchange of India Limited (As Per NSE Circular Dated on 04.10.2023)

Themis Medicare: Related News

No record found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.